发明名称 Human <i>Streptococcus pneumoniae </i>antibodies and uses therefor
摘要 The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of Streptococcus pneumoniae infections. In particular, these antibodies may kill Streptococcus pneumoniae or limit the replication of Streptococcus pneumoniae. Also disclosed are improved methods for producing such monoclonal antibodies.
申请公布号 US9279815(B2) 申请公布日期 2016.03.08
申请号 US201313740934 申请日期 2013.01.14
申请人 OKLAHOMA MEDICAL RESEARCH FOUNDATION 发明人 Smith Kenneth
分类号 C07K16/12;G01N33/68;G01N33/569 主分类号 C07K16/12
代理机构 Foley & Lardner LLP 代理人 Villacorta Gilberto M.;Mock Jason;Foley & Lardner LLP
主权项 1. A method of treating a Streptococcus pneumoniae infection in a subject comprising administering to said subject at least one antibody that binds selectively to Streptococcus pneumonia, wherein said antibody comprise i) a heavy chain [CDR] selected from the group consisting of the nucleotide sequence set forth in SEQ ID NOS: 127, 122, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 161, 162, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, and 238; and ii) a light chain [CDR] selected from the group consisting of the nucleotide sequence set forth SEQ ID NOS: 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, and 252.
地址 Oklahoma City OK US